PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.13%
Net income growth at 75-90% of AVGO's 27.27%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
5.94%
Some D&A expansion while AVGO is negative at -16.74%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1921.79%
Negative yoy deferred tax while AVGO stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.71%
SBC growth while AVGO is negative at -7.58%. John Neff would see competitor possibly controlling share issuance more tightly.
148.52%
Well above AVGO's 100.00% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-40.00%
Both yoy AR lines negative, with AVGO at -316.47%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-14.71%
Both reduce yoy inventory, with AVGO at -210.45%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-107.83%
Negative yoy AP while AVGO is 383.53%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
1868.39%
Growth well above AVGO's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
1338.38%
Some yoy increase while AVGO is negative at -2375.20%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
33.45%
Operating cash flow growth above 1.5x AVGO's 9.08%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-45.28%
Negative yoy CapEx while AVGO is 18.03%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-25.46%
Both yoy lines negative, with AVGO at -250.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
133.18%
We have some liquidation growth while AVGO is negative at -10.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-4576.99%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
6.81%
We have mild expansions while AVGO is negative at -31.82%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-191.09%
Both yoy lines negative, with AVGO at -69.10%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.